News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Mazor Robotics Receives Second Purchase Order for Renaissance™ System From Russia Distribution Partner Neuroproject Ltd.



9/26/2013 10:39:27 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd. (TASE: MZOR) (NASDAQCM: MZOR), the developer of Renaissance™, an innovative surgical guidance system and its complementary products, announced today that it received a Renaissance system order from its Russian distribution partner, Neuroproject Ltd. Russia remains an important market for the Company, as it now has a total of six surgical guided systems installed, primarily in Moscow. Neuroproject Ltd. will place the Renaissance system at City Clinical Hospital, #67, which is part of the Moscow City HealthCare Department. City Clinical Hospital, #67, is one of the largest multi-field medical and preventive treatment facilities of Moscow. The hospital employs highly skilled professionals, including 5 Doctors of Medical Science and 45 Candidates of Medical Science; more than 100 physicians have the highest qualification class. More than 14,000 surgeries are performed annually, including a great number of high-tech ones, such as spine surgery. The hospital is a clinical site for 11 sub departments of Moscow’s medical universities.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES